Form 4: Sotera Health Director Receives Equity Grant

Director Richard G. Kyle was granted 14,970 restricted stock units as part of the Sotera Health Company 2020 Omnibus Incentive Plan.

Summary

• Director Richard G. Kyle acquired 14,970 restricted stock units (RSUs) on May 22, 2026.
• Each RSU represents a right to receive one share of common stock.
• The grant is subject to vesting conditions based on continued service as a non-employee director.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• Alignment of director interests with shareholders through equity-based compensation.

Negatives

• None identified.

Risks

• Vesting is contingent upon the director's continued service to the company.

Future Outlook

The RSUs will vest in full on the earlier of the first anniversary of the grant date or the date immediately prior to the next regular annual shareholders meeting.

Industry Context

StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practice to ensure long-term alignment with shareholder value in the healthcare services sector.

Comparison to Industry Standards

• The grant of restricted stock units is consistent with standard director compensation packages for mid-cap healthcare companies.
• Vesting schedules tied to annual shareholder meetings are common practice for board members.

Stakeholder Impact

• Minor dilution impact for existing shareholders upon eventual vesting and issuance of shares.

Next Steps

• Vesting of RSUs on the earlier of May 22, 2027, or the date of the next annual shareholders meeting.

Key Dates

Keywords

Sotera Health, SHC, Form 4, Insider Transaction, Equity Grant, Director Compensation